Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of 22Q11.2 deletion syndrome with cannabidiol

Treatment of 22Q11.2 deletion syndrome with cannabidiol

US Patent 12186282 · Granted Jan 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of behavioral impairment in developmental and epileptic encephalopathy2025
Treatment of behavioral impairment in developmental and epileptic encephalopathy2025
Treatment of fragile X syndrome with cannabidiol2025
Treatment of fragile X syndrome with cannabidiol2025
Treatment of autism with cannabidiol2025
Treatment of autism with cannabidiol2025
Treatment of Fragile X Syndrome with cannabidiol2023
Treatment of Fragile X Syndrome with cannabidiol2023
Treatment of 22Q11.2 deletion syndrome with cannabidiol2022
Treatment of 22Q11.2 deletion syndrome with cannabidiol2022
Treatment of Fragile X Syndrome with cannabidiol2022
Treatment of Fragile X Syndrome with cannabidiol2022